Biocryst Pharmaceuticals reported $13.53M in Trade Creditors for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Adamas Pharmaceuticals ADMS:US 2.47M 304K
Alexion Pharmaceuticals ALXN:US $ 125.3M 6.7M
Alnylam Pharmaceuticals ALNY:US $ 53.08M 7.7M
Chemocentryx CCXI:US $ 11.09M 0.17M
Chugai Pharma 4519:JP Y 106811M 45240M
Daiichi Sankyo 4568:JP Y 266895M 30604M
Enanta Pharmaceuticals ENTA:US $ 5.9M 0.2M
Intra Cellular Therapies ITCI:US $ 15.94M 7.22M
Karyopharm Therapeutics KPTI:US $ 2.31M 731K
Mirati Therapeutics MRTX:US $ 23.87M 4.27M
Novavax NVAX:US $ 74M 39.61M
Ptc Therapeutics PTCT:US $ 20.82M 1.71M
Regeneron Pharmaceuticals REGN:US $ 476M 66.9M
Sarepta Therapeutics SRPT:US $ 76.68M 0.03M
Ultragenyx Pharmaceutical RARE:US $ 21.79M 6.05M
Vertex Pharmaceuticals VRTX:US $ 127.53M 0.3M
YTE INCY:US $ 122.1M 37.04M
Zogenix ZGNX:US $ 10.83M 1.13M